Arkolith/Insider Trading/IGMS/Form 4

Decker Lisa Lynn

CHIEF BUSINESS OFFICERIGM Biosciences, Inc. (IGMS) · full profile →Form 4 · filed Dec 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2024Sell(S)1K$7.48$8K78K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-029777) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML